3 completed. 2 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Pneumovax®: new trials by email Literature Review of Pneumovax® trials Research Report on Pneumovax®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of PCV24 in Adults Aged ≥18 Years Sinovac Low-dosage PCV24, Sinovac Middle-dosage PCV24, Sinovac High-dosage PCV24 - Pneumococcal Infectious Disease | Phase 1 / Phase 2 | Completed | Sinovac Life Sciences Co., Ltd. | 385 | 2025-06-18 | 2026-04-21 |
| Clinical Trial of PCV24 in Adults Sinovac PCV24 formulation 1, Sinovac PCV24 formulation 2, Pneumovax® - Pneumococcal Infectious Disease | Phase 1 | Completed | Sinovac Life Sciences Co., Ltd. | 170 | 2024-06-21 | 2025-04-16 |
| Pneumococcal Vaccination for Splenectomised Thalassemia Major Patients in Indonesia Zinc, Sucrose, PCV Vaccine - Thalassemia, Pneumococcal Infection | Phase 4 | Completed | Fakultas Kedokteran Universitas Indonesia | 56 | 2013-09-01 | 2017-03-29 |
Pneumococcal Infections (3) · Thalassemia (1)
Sinovac Life Sciences Co., Ltd. (2) · Fakultas Kedokteran Universitas Indonesia (1)
China (2) · Indonesia (1)
Kai Chu (1) · Teny T Sari, M.D, PhD (1) · Weijun Hu (1)